Inventor · disambiguated record
Virginia Heather Sharron Grant
Also filed as: GRANT VIRGINIA · GRANT VIRGINIA H · GRANT VIRGINIA HEATHER SHARRON
17 granted patents·7 pending applications·43 citations·filing 2010–2025
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US11634407B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Apr 25, 2023·5 cites·66 claims
- 0296US11149007B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Oct 19, 2021·14 cites·41 claims
- 0394US11325889B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted May 10, 2022·11 cites·35 claims
- 0493US11873283B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Jan 16, 2024·2 cites·34 claims
- 0593US11739075B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Aug 29, 2023·3 cites·17 claims
- 0693US11560371B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Jan 24, 2023·3 cites·18 claims
- 0782US11358952B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Jun 14, 2022·1 cites·21 claims
- 0881US12404241B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Sep 2, 2025·0 cites·16 claims
- 0980US2024217955A1Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2024·Application pending·0 cites
- 1078US2025188056A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2024·Application pending·0 cites
- 1177US11945804B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 1276US12103920B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Oct 1, 2024·0 cites·15 claims
- 1373US9144557B2Hematopoietic growth factor mimetic small molecule compounds and their usesZHI LIN·Filed 2010·Granted Sep 29, 2015·3 cites·21 claims
- 1472US12227490B2Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Feb 18, 2025·0 cites·18 claims
- 1570US11413274B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2020·Granted Aug 16, 2022·0 cites·8 claims
- 1667US9622991B2Hematopoietic growth factor mimetic small molecule compounds and their usesLIGAND PHARM INC·Filed 2015·Granted Apr 18, 2017·1 cites·23 claims
- 1766US10736875B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2018·Granted Aug 11, 2020·0 cites·16 claims
- 1861US2025100995A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Application pending·0 cites
- 1959US2024368118A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Application pending·0 cites
- 2059US2024374591A1Cereblon binding compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Application pending·0 cites
- 2157US2025382292A1Compounds for treating light chain amyloidosisPROTEGO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2255US9492430B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2012·Granted Nov 15, 2016·0 cites·12 claims
- 2353US10111859B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2016·Granted Oct 30, 2018·0 cites·8 claims
- 2451US2023357253A1Agonists of stimulator of interferon genes stingSCRIPPS RESEARCH INST·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Virginia Heather Sharron Grant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →